Vital Farms, Inc. (VITL)
NASDAQConsumer StaplesAgricultural Farm ProductsSnapshot 2026-09-04
$9.92-1.78%
Close 2026-09-04 · 1-day change
NASDAQConsumer StaplesAgricultural Farm ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · VITL
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Execute supply control initiatives, right-size supply with farmer contracts, reduce overhead, and manage costs to recover margins and return to positive shell egg volume growth.
Stated in 2 of last 2 quarters. Net revenue declined 10.1% from $184.8M in 2025-Q2 to $166.0M in 2026-Q2, with gross margin collapsing from 38.9% to 6.6% due to oversupply and price pressure. Management's focus on supply control, contract amendments, and overhead reduction is a direct response to these challenges, showing active efforts but with results still reflecting margin pressure and volume decline.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 0 of the last 3 quarter-over-quarter moves. Historically, Consumer Staples names rated weak grew net income 58% of the time over the next year (vs 56% for the rest of the cohort, n=2094).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“We narrowed our retail price gaps on a targeted, geography-by-geography basis, executed voluntary contract amendments with our farmer partners to right-size supply, and structurally reduced our overh…”
“We are acting with urgency to restore volume growth by narrowing price gaps versus other outdoor access eggs, which we believe will help reaccelerate our velocities.”
Discontinue butter business to focus on core egg categories, reduce complexity, and improve margin profile by end of fiscal 2026.
Stated in 2 of last 2 quarters. Management announced the wind down of the butter business by end of 2026 to focus on core egg products. The 2026-Q2 results included $7.8M in exit costs related to this wind down, confirming active execution. This priority is progressing as planned with clear financial impact.
“Costs related to the exit of our butter business impacted gross profit by $7.8 million in the quarter.”
“Following a comprehensive review, we have made the strategic decision to wind down the butter business by the end of fiscal 2026.”
Target net revenue of $775 million to $800 million in fiscal 2026, representing at least 5% growth over fiscal 2025.
Stated in 3 of last 3 quarters. Management's fiscal 2026 net revenue guidance ranges from $775M to $800M, targeting at least 5% growth over fiscal 2025's $759.4M. The guidance was lowered from earlier $900-$920M but remains consistent in recent quarters, reflecting a cautious but growth-oriented trajectory.
“We reaffirm our full-year 2026 guidance of net revenue of $775 million to $800 million, at least 5% growth versus 2025.”
“We expect net revenue of $775 million to $800 million, representing at least 5% growth versus fiscal year 2025.”
“Fiscal 2026 Guidance of $900 to $920 million for Net Revenue, representing up to 21% Growth from 2025.”
Slow pace of capital spending, especially at Vital Crossroads and accelerator farms, to better align capacity additions with demand realization.
Stated in 2 of last 2 quarters. Management reduced 2026 capital expenditure guidance from $140-$150M to $70-$75M to better align capacity with demand. Actual capex was $37.5M in first half 2026, up from $10M prior year, indicating ongoing investment but at a moderated pace consistent with stated priorities.
“Capital expenditures are expected to be in the range of $70 million to $75 million, reflecting the decision to slow the pace of capital spending.”
“We are proactively tightening our cost structure and aligning our capital allocation to prioritize operational discipline and margin protection.”
Strengthen liquidity profile with new credit facilities and manage capital allocation prudently, including stock repurchase program adjustments.
Stated in 2 of last 2 quarters. Management strengthened liquidity with new $125M term loan and $60M asset-based lending facility in 2026-Q2, replacing prior credit. The Board terminated the $100M stock repurchase program in 2026-Q2 to maintain financial flexibility. This reflects active capital allocation discipline aligned with stated priorities.
“Announces new $125 million term loan and $60 million asset-based lending facilities, terminating stock repurchase program.”
“Stock repurchase program authorized for up to $100 million, reflecting confidence in long-term growth trajectory.”
Over the trailing year it converted 0.83x of net income into operating cash flow. Historically, Consumer Staples names rated neutral grew net income 52% of the time over the next year (vs 57% for the rest of the cohort, n=2083).
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity (low R² over the window).
9 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Consumer Staples names rated neutral grew net income 51% of the time over the next year (vs 52% for the rest of the cohort, n=1251).
Not investment advice. As of 2026-09-04.